FoxM1B Regulates NEDD4-1 Expression, Leading to Cellular Transformation and Full Malignant Phenotype in Immortalized Human Astrocytes

被引:73
作者
Dai, Bingbing
Pieper, Russell O. [6 ]
Li, Dawei
Wei, Ping
Liu, Mingguang
Woo, Shiao Y. [2 ]
Aldape, Kenneth D. [3 ,4 ]
Sawaya, Raymond
Xie, Keping [4 ,5 ]
Huang, Suyun [1 ,4 ]
机构
[1] Univ Texas MD Anderson Canc Ctr, Dept Neurosurg, Unit 1004, Houston, TX 77030 USA
[2] Univ Texas MD Anderson Canc Ctr, Dept Radiat Oncol, Houston, TX 77030 USA
[3] Univ Texas MD Anderson Canc Ctr, Dept Pathol, Houston, TX 77030 USA
[4] Univ Texas MD Anderson Canc Ctr, Dept Gastrointestinal Med Oncol, Houston, TX 77030 USA
[5] Univ Texas Grad Sch Biomed Sci Houston, Program Canc Biol, Houston, TX USA
[6] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA
关键词
GROWTH-FACTOR RECEPTOR; LOW-GRADE GLIOMAS; TRANSCRIPTION FACTOR; TUMOR-SUPPRESSOR; GLIOBLASTOMA-MULTIFORME; SURVIVIN EXPRESSION; SIGNALING PATHWAY; PTEN; PROLIFERATION; PROGRESSION;
D O I
10.1158/0008-5472.CAN-09-3909
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Our recent studies have shown that the FoxM1B transcription factor is overexpressed in human glioma tissues and that the level of its expression correlates directly with glioma grade. However, whether FoxM1B plays a role in the early development of glioma (i.e., in transformation) is unknown. In this study, we found that the FoxM1B molecule causes cellular transformation and tumor formation in normal human astrocytes (NHA) immortalized by p53 and pRB inhibition. Moreover, brain tumors that arose from intracranial injection of FoxM1B-expressing immortalized NHAs displayed glioblastoma multiforme (GBM) phenotypes, suggesting that FoxM1B overexpression in immortalized NHAs not only transforms the cells but also leads to GBM formation. Mechanistically, our results showed that overexpression of FoxM1B upregulated NEDD4-1, an E3 ligase that mediates the degradation and downregulation of phosphatase and tensin homologue (PTEN) in multiple cell lines. Decreased PTEN in turn resulted in the hyperactivation of Akt, which led to phosphorylation and cytoplasmic retention of FoxO3a. Blocking Akt activation with phosphoinositide 3-kinase/Akt inhibitors inhibited the FoxM1B-induced transformation of immortalized NHAs. Furthermore, overexpression of FoxM1B in immortalized NHAs increased the expression of survivin, cyclin D1, and cyclin E, which are important molecules for tumor growth. Collectively, these results indicate that overexpression of FoxM1B, in cooperation with p53 and pRB inhibition in NHA cells, promotes astrocyte transformation and GBM formation through multiple mechanisms. Cancer Res; 70(7); 2951-61. (C) 2010 AACR.
引用
收藏
页码:2951 / 2961
页数:11
相关论文
共 49 条
[1]   Phosphoinositide 3-kinase activation regulates cell division time by coordinated control of cell mass and cell cycle progression rate [J].
Alvarez, B ;
Garrido, E ;
Garcia-Sanz, JA ;
Carrera, AC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (29) :26466-26473
[2]  
[Anonymous], 2009, CANC FACTS FIG
[3]   Survivin expression is regulated by coexpression of human epidermal growth factor receptor 2 and epidermal growth factor receptor via phosphatidylinositol 3-kinase/AKT signaling pathway in breast cancer cells [J].
Asanuma, H ;
Torigoe, T ;
Kamiguchi, K ;
Hirohashi, Y ;
Ohmura, T ;
Hirata, K ;
Sato, M ;
Sato, N .
CANCER RESEARCH, 2005, 65 (23) :11018-11025
[4]   Epidermal growth factor receptor and Ink4a/Arf:: Convergent mechanisms governing terminal differentiation and transformation along the neural stem cell to astrocyte axis [J].
Bachoo, RM ;
Maher, EA ;
Ligon, KL ;
Sharpless, NE ;
Chan, SS ;
You, MJJ ;
Tang, Y ;
DeFrances, J ;
Stover, E ;
Weissleder, R ;
Rowitch, DH ;
Louis, DN ;
DePinho, RA .
CANCER CELL, 2002, 1 (03) :269-277
[5]   Quantitatively determined survivin expression levels are of prognostic value in human gliomas [J].
Chakravarti, A ;
Noll, E ;
Black, PM ;
Finkelstein, DF ;
Finkelstein, DM ;
Dyson, NJ ;
Loeffler, JS .
JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (04) :1063-1068
[6]  
Chakravarti A, 2001, CLIN CANCER RES, V7, P2387
[7]   Comprehensive genomic characterization defines human glioblastoma genes and core pathways [J].
Chin, L. ;
Meyerson, M. ;
Aldape, K. ;
Bigner, D. ;
Mikkelsen, T. ;
VandenBerg, S. ;
Kahn, A. ;
Penny, R. ;
Ferguson, M. L. ;
Gerhard, D. S. ;
Getz, G. ;
Brennan, C. ;
Taylor, B. S. ;
Winckler, W. ;
Park, P. ;
Ladanyi, M. ;
Hoadley, K. A. ;
Verhaak, R. G. W. ;
Hayes, D. N. ;
Spellman, Paul T. ;
Absher, D. ;
Weir, B. A. ;
Ding, L. ;
Wheeler, D. ;
Lawrence, M. S. ;
Cibulskis, K. ;
Mardis, E. ;
Zhang, Jinghui ;
Wilson, R. K. ;
Donehower, L. ;
Wheeler, D. A. ;
Purdom, E. ;
Wallis, J. ;
Laird, P. W. ;
Herman, J. G. ;
Schuebel, K. E. ;
Weisenberger, D. J. ;
Baylin, S. B. ;
Schultz, N. ;
Yao, Jun ;
Wiedemeyer, R. ;
Weinstein, J. ;
Sander, C. ;
Gibbs, R. A. ;
Gray, J. ;
Kucherlapati, R. ;
Lander, E. S. ;
Myers, R. M. ;
Perou, C. M. ;
McLendon, Roger .
NATURE, 2008, 455 (7216) :1061-1068
[8]  
Choe G, 2003, CANCER RES, V63, P2742
[9]   Aberrant FoxM1B expression increases matrix metalloproteinase-2 transcription and enhances the invasion of glioma cells [J].
Dai, B. ;
Kang, S-H ;
Gong, W. ;
Liu, M. ;
Aldape, K. D. ;
Sawaya, R. ;
Huang, S. .
ONCOGENE, 2007, 26 (42) :6212-6219
[10]  
Ermoian RP, 2002, CLIN CANCER RES, V8, P1100